Lynsey Gray

  1. Accessing edaravone in your country - the new FDA approved drug for ALS

    What are the results from the clinical studies that led to the approval of edaravone, and how can patients access it in their country?

    edaravone FDA ALS

    Read more »
  2. Apps that help patients stay connected to their friends and family

    As a patient, would you benefit from apps that alerted your support network every time you visited the hospital or had a few spare minutes to chat? Almost definitely, right?

    apps for patients

    Read more »
  3. The three (free!) things that patients told us helped them get through their worst days.

    Fighting an illness is rarely as simple as diagnosis-plus-medication-equals-improved-health.

    woman smiling

    Read more »
  4. 20 Things You Need to Include in your Hospital Bag

    We asked our community of patients what they recommend packing in a hospital bag, and the response was overwhelming.

    luggage

    Read more »
  5. Nivolumab Dominates the News

    Promising Results from Multiple Studies

    nivolumab news

    Read more »
  6. Daratumumab approved as multiple myeloma treatment

    The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments. 

    Daratumumab multiple myeloma treatment

    Read more »
  7. If you have ALS

    If you are experiencing ALS too, this page was written specifically for you.

    Garmt van Soest

    Read more »
  8. 10 Things You Need To Know About Multiple Myeloma

    Multiple myeloma is a treatable but incurable blood cancer that typically occurs in the bone marrow. 

    a couple kissing

    Read more »
  9. 8 Gifts Patients Really Want (From Real Patients!)

    When someone you love is battling illness, it’s natural to want to reach out and help in any way you can. Knowing how you can help isn’t always so clear.

    bed

    Read more »
  10. Alectinib approved for the treatment of ALK-positive NSCLC

    A new treatment that targets a specific type of lung cancer has received FDA approval. 

    Alectinib treatment ALK-positive NSCLC

    Read more »
Posts loader